World’s Largest Tobacco Company Continues Silent Entry Into Cannabis: Is Philip Morris A Medical Marijuana Supporter?
Philip Morris Intl. expands into cannabis via Avicanna partnership, focusing on medical research and innovation: How this ...
Philip Morris’s Zyn nicotine pouch isn’t safe, but FDA gives OK to marketing it
Shares of Philip Morris extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the ...
Philip Morris Targets Expansion In Egypt After IQOS Success
IQOS's success in Egypt signals a promising opportunity for the introduction of additional smoke-free products to the market, ...
Zacks.com on MSN5d
Philip Morris Resilient on Smoke-Free Transition Efforts and Pricing
PM's solid fundamentals and commitment to innovation and cost efficiencies position the company well for sustained growth ...
Hosted on MSN3d
Morgan Stanley Initiates Coverage of Philip Morris International (PM) with Overweight Recommendation
Fintel reports that on January 16, 2025, Morgan Stanley initiated coverage of Philip Morris International (NYSE:PM) with a ...
Philip Morris stock rises on FDA's first nicotine pouch approval
Matthew Farrelly, Ph.D., director of the Office of Science in the FDA’s Center for Tobacco Products, stated, “In this case, ...
Philip Morris: Shift To Smoke-Free Sparks Steady Dividend Growth
Learn how Philip Morris International plans to shift to smoke-free products by 2030 to mitigate risks, boost profits, and ...
Philip Morris: Growth Potential in Smoke-Free Product Portfolio Fuels Buy Rating
Morgan Stanley analyst Eric Serotta has maintained their bullish stance on PM stock, giving a Buy rating on January 10.Stay Ahead of the ...
Philip Morris' Zyn nicotine pouches land FDA marketing approval
Tobacco stocks gained slightly on Thursday after the FDA has authorized the marketing of 20 Zyn nicotine pouch products ...
Assenagon Asset Management S.A. Decreases Stake in Philip Morris International Inc. (NYSE:PM)
Assenagon Asset Management S.A. lessened its holdings in shares of Philip Morris International Inc. (NYSE:PM – Free Report) ...
Philip Morris Gains Competitive Edge with FDA Authorization of ZYN Nicotine Pouches
Analyst Matthew Smith of Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report), with a price target of ...
Philip Morris Shares Advance 1% After FDA Authorizes Marketing of Zyn
Philip Morris International shares edged up slightly after the Food and Drug Administration authorized marketing for 20 Zyn nicotine-pouch products. The stock rose about 1%, to $119.40, late Thursday ...